FDA

Enforcement Report

The FDA Enforcement Report is published weekly by the Food and Drug Administration, U.S. Public Health Service, Department of Health and Human Services. It contains information on actions taken in connection with agency regulatory activities.

April 9, 1997                                  97-15

RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS II ===========
_______________
PRODUCT        (a) Transfilled Medical Oxygen in D, E, J, MPs
               and K cylinders; (b) Liquid Medical Oxygen. 
               Recall #D-132/133-7.
CODE           All codes, all lots, and all fill dates.
MANUFACTURER   Lewin Agency, Inc., doing business as Lewin
               Medical Supply, Riverhead, New York.
RECALLED BY    Manufacturer, by telephone on March 18, 1997,
               followed by letter.  Firm-initiated recall
               ongoing.
DISTRIBUTION   New York.
QUANTITY       132 cylinders and 2 31-liter cryogenic vessels
               were distributed.
REASON         Current good manufacturing practice
               deficiencies (FDA inspection found that
               product was not tested for strength and the
               oxygen analyzer was not properly maintained).

_______________
PRODUCT        Clindamycin Phosphate Injection, USP, 150
               mg/ml, Rx small volume parenteral
               semisynthetic antibiotic for IV or IM
               administration for the treatment of serious
               infections caused by susceptible anaerobic
               bacteria; packaged in 2 ml, 4 ml and 6 ml
               single dose vials, 25 vials per box.  
               Recall #D-137-7.CODE           Catalog 22602, 2 ml fill in 2 ml vial,    
               Catalog 22604, 4 ml fill in 5 ml vial, 
               Catalog 22606, 6 ml fill in 10 ml vial. 
               Lot numbers 951067, 951069, 951222, 951235,
               960639, 951040, 951084, 951146, 960126, 960618
MANUFACTURER   SoloPak Pharmaceuticals Inc., Elk Grove
               Village, Illinois.
RECALLED BY    Manufacturer, by letter dated March 13, 1997. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       320,000 vials were distributed; firm estimated
               that 1 percent of product remained on market
               at time of recall initiation.
REASON         Bulk Clindamycin was recalled by Roussel
               Corporation (parent firm of Biochimica Opos)
               due to AADA discrepancies regarding the
               manufacturing process; AADA was withdrawn.

_______________
PRODUCT        Clindamycin Phosphate Injection, USP sterile
               solution (150mg/ml) in 2ml, 4ml, 6ml, and 60ml
               single dose containers (SDC) which are
               packaged 25 SDCs per intermediate carton, a
               prescription drug given intramuscularly or
               intravenously for the treatment of serious
               infections caused by susceptible anaerobic
               bacteria.  Recall #D-138-7.
CODE           (2ml) Lot Nos. 1450605038, 1450608035.
               (4ml) Lot Nos. 1451509066, 1451601040,
               1451603105, 1451605035, 1451606048,
               1451609805, and 1451609806.
               (6ml) Lot Nos. 1452509065, 1452603109,
               1452605033, 1452606051, and 1452609804.
               Lot Nos. 1453510021, 1453601100 and
               1453610040.     
MANUFACTURER   Astra USA Inc. Westboro, Massachusetts.
RECALLED BY    Manufacturer, by letter dated March 20, 1997. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       47,757 saleable units were distributed; firm
               estimated that 3,100 units of product shipped
               prior to January 31, 1997, were still in
               distribution at time of recall initiation.
REASON         Bulk Clindamycin was recalled by Roussel
               Corporation (parent firm of Biochmicia Opos)
               due to AADA discrepancies regarding the
               manufacturing process; AADA was withdrawn.

_______________
PRODUCT        Phenytoin Oral Suspension, USP packaged in
               unit dose cups and oral syringes, Rx oral
               antiepileptic drug, unit dose cups are
               packaged 10 cups per tray, with 5 or 10 trays
                             -2-               per case, 100 mg 4-ml unit dose cup, 50
               cups/case; 100 mg 4-ml unit dose cup, 100
               cups/case; 100 mg 4-ml oral syringe, 50
               syringes/case; 300 mg 12-ml unit dose cup, 100
               cups/case.  Recall #D-140-7. 
 CODE          All lots within expiration date -- 605609,
               604610, 603614, 603613, 603601, 602802,
               602606, 602605, 601612, 601614, 512609,
               512604, 512606, 512607, 512603, 511606,
               511605, 510604, 510606, 510607, 509612,
               509607, 509606, 509612.
MANUFACTURER   Parke-Davis, Division of Warner-Lambert
               Company, Morris Plains, New Jersey.
RECALLED BY    Xactdose, Inc., South Beloit, Illinois
               (repacker), by letter dated March 4, 1997. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       6,116 cases of 50/4 ml cups, 15,372 cases of
               100/4 ml cups, 174 cases of 100/12 ml cups,
               and 116 cases of 50/4 ml oral syringes were
               distributed; firm estimates that little, if
               any, product remains on the market.
REASON         Product failed content uniformity test.


RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS III ==========
_______________
PRODUCT        Dexamethasone Sodium Phosphate for Injection,
               USP, 10 mg/ml, in 10 ml multi-dose vials,
               sterile, injectable glucocorticoid, under the
               following labels:  Steris, Schein, Clint, and
               Robar.  Recall #D-136-7.
CODE           LOT      EXPIRATION
               95E710    7/97
               95F530    9/97
               95K460   11/97
               95L190   11/97
               95L770   12/97
               96C420    3/98
               96H430    7/98.
MANUFACTURER   Steris Laboratories, Inc., Phoenix, Arizona.
RECALLED BY    Manufacturer, by letter dated January 27,
               1997.  Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide, Puerto Rico, Peru.
QUANTITY       Approximately 94,500 vials were distributed.
REASON         Product failed pH specification (SPEC is 7.0-
               8.5pH); actual is 8.6.

_______________
PRODUCT        Trisoralen Tablets, 5 mg. (Trioxsalen, USP),
               packaged in bottles of 28 tablets and 100
               tablets, (bottles of 10 and 1000 were 

                             -3-               exported), a prescription drug for oral
               administration and is indicated for the
               repigmentation of idiopathic vitiligo; for
               increasing tolerance to sunlight and for
               enhancing pigmentation.  Recall #D-139-7.
CODE           All lot numbers (18 total) within expiration
               date are under recall.  The lot numbers and
               expiration dates which identify domestic, and
               possibly, foreign distribution are: E0216
               (2/97), E0503 (5/97), E1107 (11/97), E1124
               (12/97), F0102 (2/98), F0219 (3/98), F0408A
               (5/98), F0408B (5/98), F1217B (1/99), F1217B
               (1/99), G0816A (9/99), G0816B (9/99), G1001A
               (11/99), G1001B (11/99), H0321A (5/00), H312B
               (5/00), H0831A (9/98), H1122B (12/98).  
               The lot numbers which exclusively identify
               international distribution are:  E1228,
               F0403A, F0403B, F0219E, F0408AE, F0408BE,
               F0801A, F0801B, H0831B, & H1122A.  
MANUFACTURER   ICN Pharmaceuticals, Inc., Inc., Costa Mesa,
               California (responsible firm).
RECALLED BY    ICN Pharmaceuticals, Inc., Bryan, Ohio, by
               letter dated February 25, 1997.  Firm-
               initiated recall ongoing.
DISTRIBUTION   Nationwide and international.
QUANTITY       58,514 bottles were shipped to domestic
               accounts.
REASON         Product fails dissolution test requirements
               (SPEC is NLT 75%; actual is as low as 45%).


RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS II =======
_______________
PRODUCT        Red Blood Cells.  Recall #B-507-7.
CODE           Unit #12LP09541.
MANUFACTURER   American Red Cross Blood Services, Charlotte,
               North Carolina.
RECALLED BY    Manufacturer, by letter dated May 8, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   North Carolina.
QUANTITY       1 unit was distributed.
REASON         Blood product tested negative for the antibody
               to the hepatitis B core antigen (anti-HBc),
               but was collected from a donor who previously
               tested repeatedly reactive for anti-HBc on two
               separate occasions.

                             -4-_______________
PRODUCT        (a) Red Blood Cells; (b) Platelets.
               Recall #B-530/531-7.
CODE           Unit numbers:  (a) 25GX16989, 25GX24532; 
               (b) 25GX16989.
MANUFACTURER   American Red Cross Blood Services, Syracuse,
               New York.
RECALLED BY    Manufacturer, by letter dated June 28, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   New York.
QUANTITY       (a) 2 units; (b) 1 unit was distributed.
REASON         Blood products were collected from a donor who
               reported a history of intravenous (IV) drug
               use.

_______________
PRODUCT        (a) Red Blood Cells; (b) Recovered Plasma.
               Recall #B-533/534-7.
CODE           Unit #26146-9450.
MANUFACTURER   United Blood Services, Fort Smith, Arkansas.
RECALLED BY    Blood Systems, Inc., Scottsdale, Arizona, by
               letter dated October 16, 1996.  Firm-initiated
               recall complete.
DISTRIBUTION   Arkansas and Switzerland.
QUANTITY       1 unit of each component was distributed.
REASON         Blood products confirmed positive for
               syphilis.

_______________
PRODUCT        Red Blood Cells.  Recall #B-536-7.
CODE           Unit #53H38588.
MANUFACTURER   American Red Cross Blood Services, Baltimore,
               Maryland.
RECALLED BY    Manufacturer, by letter dated October 31,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Maryland.
QUANTITY       1 unit was distributed.
REASON         Blood product was collected from a donor who
               reported travel to an area considered endemic
               for malaria.

_______________
PRODUCT        Red Blood Cells.  Recall #B-537-7.
CODE           Unit #53LN09463.
MANUFACTURER   American Red Cross Blood Services, Baltimore,
               Maryland.
RECALLED BY    Manufacturer, by letter dated October 31,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Maryland.
QUANTITY       1 unit was distributed.
REASON         Blood product was collected from a donor who
               reported travel to an area considered endemic
               for malaria.
                             -5-_______________
PRODUCT        Red Blood Cells.  Recall B-538-7.
CODE           Unit numbers:  25GE31781, 25GE33113,
               01GX00010.
MANUFACTURER   American Red Cross Blood Services,
               Schenectady, New York.
RECALLED BY    Manufacturer, by letters dated November 21 or
               25, 1996.  Firm-initiated recall complete.
DISTRIBUTION   New York.
QUANTITY       3 units were distributed.
REASON         Blood products were collected from a donor who
               reported travel to an area considered endemic
               for malaria.

_______________
PRODUCT        (a) Platelets; (b) Fresh Frozen Plasma. 
               Recall #B-540/541-7.
CODE           Unit #13L80117.
MANUFACTURER   American Red Cross, Detroit, Michigan.
RECALLED BY    Manufacturer, by letter dated October 17,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Michigan.
QUANTITY       1 unit of each component was distributed.
REASON         Blood products corresponding to Red Blood
               Cells were returned because of confirmed clots
               present in the bag segments.

_______________
PRODUCT        (a) Red Blood Cells; (b) Platelets; (c)
               Recovered Plasma.  Recall #B-542/544-7.
CODE           Unit numbers:  (a) 16LC00616, 16LC01290; (b)
               16LC00616; (c) 16LC00616, 16LC01290.
MANUFACTURER   American Red Cross, Columbus, Ohio.
RECALLED BY    Manufacturer, by letter dated November 20,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Ohio and California.
QUANTITY       (a) 2 units; (b) 1 unit; (c) 2 units were
               distributed.
REASON         Blood products were collected from a donor
               currently taking the drug Imuran.

_______________
PRODUCT        Various allergenic extracts: 
               (a) Standardized Allergenic Extract Mite
               Dermatophagoides pteronyssinus, 30,000 AU/Ml  
               (b) Standardized Allergenic Extract Mite
               Dermatophagoides pteronyssinus Intradermal
               Test 
               (c) Standardized Allergenic Extract Mite
               Mixture (Dermatophagoides farinae and
               Dermatophagoides pteronyssinus 15,000 AU/Ml. 
               Recall #B-546/548-7.
                             -6-CODE           Lot numbers:  (a) J76D1321, 10 ml, EXP
               10/01/98; J76B2719, 30 ml, EXP 10/01/98;
               J76B2724, 30 ml, EXP 10/01/98  
               (b) C66C5638, 30 AU/ml, 5 ml, EXP 3/01/97;     
               C66C56636, 300 AU/ml, 5 ml, EXP /01/97
               (c) J75L6368, 30 ml, EXP 10/01/98.
MANUFACTURER   Bayer Corporation Pharmaceutical Division     
               Allergy Products, Spokane, Washington.
RECALLED BY    Manufacturer, by letter on February 15, 1997.
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide and international.
QUANTITY       558 vials were distributed.
REASON         Product contains a percentage of
               Dermatophagoides farinae not listed on the
               product labeling.           

_______________
PRODUCT        Platelets, Pheresis.  Recall #B-550-7.
CODE           Unit #7138971.
MANUFACTURER   Oklahoma Blood Institute, Enid, Oklahoma.
RECALLED BY    Manufacturer, by fax on January 25, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Oklahoma
QUANTITY       1 unit was distributed.
REASON         Blood product was labeled with an extended
               expiration date.

_______________
PRODUCT        (a) Red Blood Cells; (b) Platelets.  
               Recall #B-553/554-7.
CODE           Unit #10001251.
MANUFACTURER   Stewart Regional Blood Center, Tyler, Texas.
RECALLED BY    Manufacturer, by letter dated February 13,
               1997.  Firm-initiated recall complete.
DISTRIBUTION   Texas.
QUANTITY       1 unit of each component was distributed.
REASON         Blood products were collected from a donor who
               reported a history of intravenous (IV) drug
               use.

_______________
PRODUCT        Red Blood Cells.  Recall #B-556-7.
CODE           Unit #2410898.
MANUFACTURER   Carter Blood Center, Fort Worth, Texas.
RECALLED BY    Manufacturer, by telephone on February 5,
               1997.  Firm-initiated recall complete.
DISTRIBUTION   Texas.
QUANTITY       1 unit was distributed.
REASON         Blood product tested positive For CMV antibody
               was labeled as negative.


                             -7-RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS III ======
_______________
PRODUCT        Red Blood Cells.  Recall #B-529-7.
CODE           Unit numbers:  7002639, 7002640, 8048513,
               8048514, 8050645, 8050835, 8957098, 8957100,
               8959172, 8959290, 8959328, 8961602, 8961688,
               8961736, 8963668, 8964467, 8969627, 8970015,
               8971367, 8972928 .
MANUFACTURER   West Tennessee Regional Blood Center, Inc.,
               doing business as Lifeline Blood Services,
               Jackson, Tennessee.
RECALLED BY    Manufacturer, by telephone between April 11 
               and 22, 1996.  Firm-initiated recall complete.
DISTRIBUTION   Tennessee and Massachusetts.
QUANTITY       20 units were distributed.
REASON         Blood products were labeled with an extended
               expiration date.

_______________
PRODUCT        Red Blood Cells.  Recall #B-532-7.
CODE           Unit #26147-0791.
MANUFACTURER   United Blood Services, Fort Smith Arkansas.
RECALLED BY    Blood Systems, Inc., Scottsdale, Arizona, by
               letter dated October 16, 1996.  Firm-initiated
               recall complete.
DISTRIBUTION   Arkansas.
QUANTITY       1 unit was distributed.
REASON         Blood product may have remained at room
               temperature for an unacceptable length of
               time.

_______________
PRODUCT        Fresh Frozen Plasma.  Recall #B-535-7.
CODE           Unit #26147-2256.
MANUFACTURER   United Blood Services, Fort Smith, Arkansas.
RECALLED BY    Blood Systems, Inc., Scottsdale, Arizona, by
               telephone on November 22, 1996.  Firm-
               initiated recall complete.
DISTRIBUTION   Arkansas.
QUANTITY       1 unit was distributed.
REASON         Blood product was prepared from a unit of
               whole blood designated as a difficult
               collection.

_______________
PRODUCT        Red Blood Cells.  Recall #B-539-7.
CODE           Unit #C 65576.
MANUFACTURER   Regional Health Resources Center, Community
               Blood Services of Illinois, Urbana, Illinois.

                             -8-RECALLED BY    Manufacturer, by telephone on July 28, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Illinois.
QUANTITY       1 unit was distributed.
REASON         Blood product developed small clots in the bag
               during the collection process thus preventing
               the transfusion of the entire unit.

_______________
PRODUCT        Red Blood Cells.  Recall #B-545-7.
CODE           Unit #KE59945.
MANUFACTURER   Virginia Blood Services, Richmond, Virginia.
RECALLED BY    Manufacturer, by telephone on December 5,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Virginia.
QUANTITY       1 unit was distributed.
REASON         Blood product was collected from a donor who
               confidentially excluded the unit.

_______________
PRODUCT        Abbott HTLV-1 2.0 EIA Diagnostic Kit Human T-
               Lymphtropic Virus Type I.  Recall #B-549-7.
CODE           Lot #2137M301, 21307M302 EXP 3-31-97.
MANUFACTURER   Abbott Laboratories, Diagnostic Division,
               Abbott Park, Illinois.
RECALLED BY    Manufacturer, by telephone on March 10, 1997,
               followed by letter. Firm-initiated recall
               complete.
DISTRIBUTION   Nationwide and international.
QUANTITY       202 kits were distributed
REASON         Reconstituted HTLV-I 2.0 EIA Conjugate does
               not consistently meet the Positive Control
               validity requirement.

_______________
PRODUCT        Recovered Plasma.  Recall #B-552-7.
CODE           Unit #21FJ04987.
MANUFACTURER   American Red Cross Blood Services, Pacific
               Northwest Regional Blood Services, Portland,
               Oregon.
RECALLED BY    Manufacturer, by fax on February 3, 1997. 
               Firm-initiated recall complete.
DISTRIBUTION   California.
QUANTITY       1 unit was distributed.
REASON         Blood product was collected from a donor who
               reported a history of cancer.

_______________
PRODUCT        Gamma Reagent Red Blood Cells, 3-4%, for
               antibody detection:
               (a) Duet Reagent Red Blood Cells
               (b) Trio 1, 2, and 3 Reagent Red Blood Cells

                             -9-               (d) Panel One Reagent Red Blood Cells
               (e) Panel Two Reagent Red Blood Cells
               (f) Panel 15 Reagent Red Blood Cells
               (g) Panel 20 Reagent Red Blood Cells.  
               Recall #B-555-7.
CODE           Lot numbers: (a) 1126\1 (Cell I), 1126/2 (Cell
               I), 1126/3 (Cell II), 1126/5 (Cell I & II),
               1126/6 (Cell I), 1126/7 (Cell I), 1203/8 (Cell
               I);
               (b) 1126/1 (Cell 3), 1126/3 (Cells 1 & 3),
               1126/5 (Cell 2), 1126/6 (Cells 1 & 3), 1203/1
               (Cells 1 & 3), 1203/2 (Cell 1);
               (c) 1203 (Cells 1, 2, & 10); (d) 1126 (Cells
               3, 7, & 10); (e) 1126/15 (Cells 3 & 14); (f)
               1210/20 (Cell 16).
MANUFACTURER   Gamma Biologicals, Inc., Houston, Texas.
RECALLED BY    Manufacturer, by priority mail and by fax
               beginning December 16, 1996, and by letter
               dated January 13, 1997.  Firm-initiated recall
               complete.
DISTRIBUTION   Nationwide.
QUANTITY       Firm estimates none remains on the market. 
               Product expired on January 11, 1997.
REASON         Reagent Red Blood Cells failed to show
               reactivity with anti-S antibodies.



RECALLS AND FIELD CORRECTIONS:  DEVICES --
CLASS II =========
_______________
PRODUCT        Premier Cryptosporidium, a rapid in vitro
               microwell EIA for the qualitative detection of
               Cryptosporidium oocyst antigen in stool. 
               Recall #Z-379-7.
CODE           Catalog No. 601196, Lot Nos. 601196.002 and
               601196.003.
MANUFACTURER   L.M.D. Laboratories, Inc., Carlsbad,
               California.
RECALLED BY    Meridian Diagnostics, Inc., Cincinnati, Ohio,
               by letter on February 14, 1997.  Firm-
               initiated recall complete.
DISTRIBUTION   Nationwide, Italy, New Zealand.
QUANTITY       61 kits were distributed.
REASON         The package insert and procedure card contain
               an error in that they state the absorbance of
               the samples is to be determined
               spectrophotometrically at a single wavelength. 
               However, correct procedure is to determine the
               absorbance at dual wavelengths.

                            -10-_______________
PRODUCT        Premier Giardia Lamblia, a rapid in vitro
               microwell EIA for the qualitative detection of
               Giardia lamblia trophozoite and cyst antigen
               in stool.  Recall #Z-380-7.
CODE           Catalog #609096, Lot numbers 609096.040 and
               609096.041.
MANUFACTURER   L.M.D. Laboratories, Inc., Carlsbad,
               California.
RECALLED BY    Meridian Diagnostics, Inc., Cincinnati, Ohio,
               by letters dated February 12 and 19, 1997. 
               Firm-initiated recall complete.
DISTRIBUTION   Nationwide, Italy, New Zealand.
QUANTITY       177 kits were distributed.
REASON         Product was manufactured so that the
               absorbance of samples is to be determined
               spectrophotometrically at dual wavelengths. 
               However, the correct procedure, as stated in
               the labeling, is to determine the absorbance
               at a single wavelength.


RECALLS AND FIELD CORRECTIONS:  DEVICES -- CLASS III ========
_______________
PRODUCT        Chocolate Agar with Enrichment, Catalog No.
               P1250, in-vitro diagnostic device.
               Recall #Z-381-7. 
CODE           Lot No. 051409. 
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on May 23, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Hawaii.
QUANTITY       100 plates were distributed.
REASON         Product was contaminated with bacteria.

_______________
PRODUCT        Inhibitory Mold Agar, in-vitro diagnostic
               device.  Recall #Z-382-7.
CODE           Catalog No. P1725, Lot No. 042922.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on May 23, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Hawaii and Washington state.
QUANTITY       30 plates were distributed.
REASON         Product was contaminated with fungus. 

_______________
PRODUCT        Sabourand Dextrose with Gentamacin, in-vitro
               diagnostic device.  Recall #Z-383-7.
CODE           Catalog No. P2307, Lot No. 040917.

                            -11-MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on May, 13, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   New York, Connecticut, Canada.
QUANTITY       60 plates were distributed.
REASON         Product was contaminated with fungus.

_______________
PRODUCT        Dnase Test Agar, In-vitro diagnostic device. 
               Recall #Z-384-7.
CODE           Catalog No. P1552. Lot No. 032606. 
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by  fax on May 8, 1996.  Firm-
               initiated recall complete.
DISTRIBUTION   Canada.
QUANTITY       170 plates were distributed.
REASON         Product was contaminated with bacteria.

_______________
PRODUCT        BHI Broth + 5% Fildes, in-vitro diagnostic
               device.  Recall #Z-385-7.
CODE           Catalog No. T6239, Lot No. 030612T.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on April 30, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Canada.
QUANTITY       610 tubes were distributed.
REASON         Product had contamination in bottom of tube.

_______________
PRODUCT        Horse Blood Agar Selective, in-vitro
               diagnostic device.  Recall #Z-386-7.
CODE           Catalog No. P1705, Lot No. 013020.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on February 6,
               1996.  Firm-initiated recall complete.
DISTRIBUTION   Montana.
QUANTITY       70 plates were distributed.
REASON         Product was contaminated with bacteria.
 
_______________
PRODUCT        Catalase Test Reagent, in-vitro diagnostic
               device:  (a) Catalog No. R6450; (b) Catalog
               No. R6452.  Recall #Z-387/388-7.
CODE           Lot Numbers:  (a) 071902A; (b) 017902A.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax on September 14, 1995. 
               Firm-initiated recall complete.
                            -12-DISTRIBUTION   Massachusetts and Canada.
QUANTITY       2 bottles were distributed.
REASON         Product was contaminated with excess gas.

_______________
PRODUCT        Gardenerella Agar, in-vitro diagnostic device. 
               Recall #Z-389-7.
CODE           Catalog No. P1675, Lot No. 122811.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on January 4, 1996. 
               Firm-initiated recall complete.
DISTRIBUTION   Oregon, Washington state, Wyoming.
QUANTITY       80 plates were distributed.
REASON         Product was contaminated with excess gas.

_______________
PRODUCT        Tryptic Soy Yeast (TSYA) + 5% Rabbit Blood,
               in-vitro diagnostic.  Recall #Z-390-7.
CODE           Catalog No. P2560, Lot No. 122024.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by discarding product on January
               4, 1996.  Firm-initiated recall complete.
DISTRIBUTION   Washington state.
QUANTITY       160 plates were distributed.
REASON         Product was contaminated with bacteria.

_______________
PRODUCT        Martin Lewis Medium Modified Pill Pocket, in-
               vitro diagnostic device.  Recall #Z-391-7.
CODE           Catalog No. P3602, Lot No. 112938 EXP 2/7/96.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by discarding remaining stock on
               January 3, 1996.  Firm-initiated recall
               complete.
DISTRIBUTION   Oregon, Washington state, Canada.
QUANTITY       1,730 plates were distributed.
REASON         Product was contaminated with fungus.

_______________
PRODUCT        Cryptosporidium QC Slides, in-vitro diagnostic
               device.  Recall #Z-392-7.
CODE           Catalog No. C1200, Lot No. 10170CA EXP
               10/18/96 
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax on  October 31, 1995. 
               Firm-initiated recall complete.
DISTRIBUTION   Canada.
QUANTITY       1 box was distributed.
REASON         Device had a low number of organisms.
                            -13-_______________
PRODUCT        Haemophilus ID Quad, in-vitro diagnostic
               device.  Recall #Z-393-7.
CODE           Catalog No. P3640, Lot No. 101044 EXP
               11/21/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by discarding remaining
               inventory on  October 13, 1997.  Firm-
               initiated recall complete.
DISTRIBUTION   Oregon, Washington state, Idaho, Canada.
QUANTITY       155 plates were distributed.
REASON         The blood section of the quad is marbled with
               agar flecks making it difficult to determine
               hemolysis.

_______________
PRODUCT        Martin Lewis Medium, in-vitro diagnostic
               device.  Recall #Z-394-7.
CODE           Catalog No. P3600, Lot No. 092636 EXP
               12/19/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, on October 16, 1995.  Firm-
               initiated recall complete.
DISTRIBUTION   Oregon, California, Canada.
QUANTITY       280 plates were distributed.
REASON         Device was contaminated with mold.

_______________
PRODUCT        Buffered Charcoal Yeast Extract Agar, in-vitro
               diagnostic device.  Recall Z-395-7.
CODE           Catalog No. P1250, Lot No. 092508 EXP
               11/20/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, on May 23, 1996.  Firm-initiated
               recall complete.
DISTRIBUTION   Washington state and Canada.
QUANTITY       45 plates were distributed.
REASON         No growth of Legionella due to a lack of
               growth supplement. 

_______________
PRODUCT        Entero HLAR Agar Quad, in-vitro diagnostic. 
               Recall #Z-396-7.
CODE           Catalog No. P3630, Lot No. 092217 EXP
               10/27/95. 
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax on September 27, 1995. 
               Firm-initiated recall complete.
DISTRIBUTION   Hawaii.
                            -14-QUANTITY       20 plates were distributed.
REASON         Device was contaminated with fungus. 

_______________
PRODUCT        Sabouraud Dextrose Agar, in-vitro diagnostic
               device.  Recall #Z-397-7.
CODE           Catalog No. P2304, Lot. No. 091117 EXP
               11/20/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on September 14,
               1995.  Firm-initiated recall complete.
DISTRIBUTION   Virginia.
QUANTITY       50 plates were distributed.
REASON         Device was contaminated with fungus.


_______________
PRODUCT        Sheep Blood/Chocolate Agar with Enrichment,
               in-vitro diagnostic device.  Recall #Z-398-7.
               Catalog No. P4400, Lot No. 090736 
               EXP 11/16/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               September 14, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   Oregon, Washington state, Idaho.
QUANTITY       230 plates were distributed.
REASON         Device was contaminated with bacteria.

_______________
PRODUCT        Martin Lewis Medium Modified, in-vitro
               diagnostic device.  Recall #Z-399-7.
CODE           Catalog No. P3600, Lot No. 082962 EXP
               11/21/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax on October 6, 1995. 
               Firm-initiated recall complete.
DISTRIBUTION   Oregon, Virginia, Kentucky, Montana, Canada.
QUANTITY       1,500 plates were distributed.
REASON         Device was contaminated with fungus.

_______________
PRODUCT        Haemophilus ID Quad, in-vitro diagnostic
               device.  Recall #Z-400-7.
CODE           Catalog No. P3460, Lot No. 062433 EXP 10/5/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax on September 1, 1995. 
               Firm-initiated recall complete.

                            -15-DISTRIBUTION   California.
QUANTITY       10 plates were distributed.
REASON         Device was contaminated with fungus. 

_______________
PRODUCT        Sabouraud Dextrose Agar, in-vitro diagnostic
               device.  Recall #Z-401-7.
CODE           Catalog No. P2300, Lot No. 082123 EXP
               11/27/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               September 15, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   Oregon, Washington state, Alaska, Hawaii,
               Michigan, Canada.
QUANTITY       1,150 plates were distributed.
REASON         Device was contaminated with fungus.

_______________
PRODUCT        Andrade's Broth - Arabinose, in-vitro
               diagnostic.  Recall #Z-402-7.
CODE           Catalog No. T6404, Lot No. 081518T EXP
               8/14/96.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by telephone on November 30,
               1995.  Firm-initiated recall complete.
DISTRIBUTION   California and Canada.
QUANTITY       30 tubes were distributed.
REASON         Device was contaminated with bacteria.

_______________
PRODUCT        Columbia Agar Base with 5% Sheep
               Blood/MacConkey Agar, in-vitro diagnostic
               device.  Recall #Z-403-7.
CODE           Catalog No. P4151, Lot No. 080841-10 EXP
               10/3/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               August 31, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   Canada.
QUANTITY       30 plates were distributed.
REASON         Device was contaminated with bacteria.

_______________
PRODUCT        Sabourand Dextrose Agar, in-vitro diagnostic
               device.  Recall #Z-404-7.
CODE           Catalog No. P2304, Lot No. 081126 EXP
               10/20/95.

                            -16-MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               September 11, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   California and Canada.
QUANTITY       140 plates were distributed.
REASON         Device was contaminated with bacteria and
               fungus.

_______________
PRODUCT        Chocolate Agar with Enrichment, in-vitro
               diagnostic device.  Recall #Z-405-7.
CODE           Catalog No. P1250, Lot No. 073113 exp 10/9/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               August 10, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   Washington state.
QUANTITY       250 plates were distributed.
REASON         Device was contaminated with bacteria.

_______________
PRODUCT        Brain Heat Infusion Agar + 5% Sheep Blood, in-
               vitro diagnostic device.  Recall #Z-406-7.
CODE           Catalog No. P1160, Lot No. 071101 EXP 9/19/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               August 30, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   Washington state, California, Alaska, Canada.
QUANTITY       290 plates were distributed.
REASON         Device was contaminated with fungus.

_______________
PRODUCT        CDC Anaerobic Blood Agar, in-vitro diagnostic
               device.  Recall #Z-407-7.
CODE           Catalog No. P1249 Lot No. 070611  EXP 9/14/95.
MANUFACTURER   Prepared Media Laboratory, Inc., Tualatin,
               Oregon.
RECALLED BY    Manufacturer, by fax and by telephone on
               September 14, 1995.  Firm-initiated recall
               complete.
DISTRIBUTION   Oregon and Canada.
QUANTITY       200 plates were distributed.
REASON         Device was contaminated with mold. 

                            -17-
RECALLS AND FIELD CORRECTIONS:  VETERINARY PRODUCTS -- CLASS II ===========
_______________
PRODUCT        Muscle Pig III CSP Medicated - Starter Pig
               Ration for Baby Pigs (100 g/ton
               chlortetracycline, 100 g/ton sulfathiazole and
               50 g/ton penicillin) - 50 lb bags. 
               Manufactured for the reduction of cervical
               abscesses, treatment of bacterial swine
               enteritis and maintenance of weight gain.
               Recall #V-032-7.
CODE           K46579 (manufactured 7/31/96)
MANUFACTURER   MFA, Inc., Kirksville, Missouri.
RECALLED BY    Manufacturer, by telephone on or about January
               8, 1997.  Firm-initiated recall complete.
DISTRIBUTION   Missouri and Iowa.
QUANTITY       114  50-pound bags were distributed. 
REASON         Product was tested by the Iowa Department of
               Agriculture and analysis showed product did
               not contain any chlortetracycline or
               penicillin.  Further testing on returned feed
               revealed product was subpotent in
               chlortetracycline (7% labeled claims),
               sulfathiazole (15% of labeled claims) and
               penicillin (14% of labeled claims).

                            -18-

END OF ENFORCEMENT REPORT FOR APRIL 9, 1997.  BLANK PAGES MAY FOLLOW.

                                   ####


End of Enforcement Report for
[FDA HOME PAGE]